About Hansa Biopharma
We are dedicated to bring innovative treatments to people living with rare immunological diseases.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Lund
- Founded
- 2007
- Company type
- Public Company
Hansa Biopharma, is a pioneering commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative and life altering treatments for patients with rare immunological conditions.
Hansa scientists are working on developing immunomodulatory treatments for organ transplants, rare IgG-mediated autoimmune conditions, and gene therapy, as well as exploring the potential application of the technology platform in oncology.
Specialties
- Biopharmaceuticals
- Clinical development
- Drug discovery
- In vitro diagnostics
- Kidney transplantation
- Autoimmune disease
- Sepsis
- Antibody glycosylation
- Orphan drug
- Immunomodulatory
- and Rare diseases
Company locations
Scheelevägen 22, Lund, 223 63, SE
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
On LinkedIn
- People linked to this company
- 137
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.